Skip to main content Skip to secondary navigation
Carolyn Bertozzi and Lily Sarafan

Philanthropic investment renames Stanford ChEM-H

The investment in Sarafan ChEM-H also accelerates transformative molecular research

Main content start

Bridging chemistry, engineering, biology, and medicine to improve human health

Sarafan ChEM-H is built for the future of research. Only by connecting chemists, engineers, biologists, and clinicians can we understand life at a molecular level and apply that knowledge to improving human health.

Sarafan ChEM-H logo

"ChEM-H is a hub of innovation that brings the power of diversity to improve human health: diversity of disciplines - life, physical and clinical sciences - and most importantly, diversity of people." 

-Carolyn Bertozzi
Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences, and HHMI Investigator

Learn more about diversity, equity, and inclusion at ChEM-H


Transforming research

The Knowledge Centers are shared resources that allow more labs to advance their research goals

Start a collaboration



Transforming human health

Faculty at Sarafan ChEM-H lead labs that tackle big problems in human health, like cancer, aging, and infectious disease

Meet our faculty



Transforming training

The next generation of scientific leaders need a new kind of scientific training

Explore training programs


CBI Group Photo, 2019

A launchpad for innovation

 A Sarafan ChEM-H partnership with Stanford Medicine, the Stanford Innovative Medicines Accelerator (IMA) is accelerating the translation of Stanford’s research discoveries into new medicines while expanding knowledge of human biology. Through its faculty expertise and Knowledge Centers, Stanford ChEM-H serves as a core engine of the IMA’s efforts to catalyze discovery.

Cycle reads "Experimental Human Biology (a better understanding of disease in humans)" and "Prototyping (better drugs and vaccines for humans," which feed into one another.

Learn more about the IMA